Maria Alice Carvalho
OncoAdvanC+ (RESOLVE)
Bilateral Meetings
- Monday 14:30 - 18:00
Organization Type
University / R&D institution / Accelerator,
Innovative anti-cancer agents: a step closer for those lacking effective treatment.
A set of novel compounds with high anticancer activity and potential to inhibit some of the most appealing targets for cancer treatment, some of which do not have effective therapies.
Cooperation Requested
- Investment/Financing